Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat
Status:
Not yet recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
A single dose study to assess the pharmacokinetics (PK) of oxycodone, when PF614 is solution
is administered alone and with nafamostat as an immediate-release (IR) solution and/or
extended-release (ER) capsule prototypes.